Using 3D printing for medical devices is becoming more common amid the COVID-19 pandemic, as demand for critical personal protective equipment (PPE) continues to outpace supply.
As traditional manufacturers’ supply chains struggle to keep up with production, healthcare providers struggle with securing the necessary supply of face shields, facemasks, gowns, respirators, and gloves. In response to the deficiency, the 3D printed medical device market has expanded.
This has brought about many regulatory questions and concerns. Here are some of the most common ones.
The FDA acknowledges the need for flexible and creative approaches to meet the high demand for medical devices, specifically PPE, as well as the potential interruptions made to the worldwide supply chain. In addition to the FDA guidance document on technical considerations for manufacturing 3D-printed medical devices, the FDA published FAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic.
Due to the circumstances of the COVID-19 outbreak, the FDA has declared several authorizations of emergency use (EUAs) to proactively aim to contain and mitigate further spread. A granted EUA allows unapproved medical devices or unapproved uses of an approved medical device to be emergently utilized to prevent, diagnose, or treat a life-threatening condition or disease, such as the novel coronavirus, when there is no available, adequate, or approved alternative. This determination included circumstances in which personal respiratory devices, ventilators, and protective accessories would be granted a EUA, which the FDA outlined in an enforcement policy.
The FDA also published a standard and an accelerated EUA template for submissions of in vitro diagnostics for the detection and diagnosis of COVID-19. Further enforcement policies have been published to address coronavirus disease diagnostic testing, sterilizers and air purifiers, gowns and gloves, and imaging systems during the COVID-19 public health emergency.
Based on the FDA’s communications and published guidance, we have the following recommendations for 3D-printing medical device companies and manufacturers:
In addition, several recommendations have been issued for consumers and healthcare providers:
While 3D printing medical devices may not provide an immediate solution to the increased demand and decreased supply of PPE during the COVID-19 pandemic, the available technology may continue to develop and aid in providing support to the healthcare industry.
What questions do you still have about 3D printing medical devices and PPE during the COVID-19 pandemic? Connect with us to discuss how we can help.